Patient-Portal vs Text-based Hypertension Monitoring Among Black Medicaid/Medicare Patients

Sponsor
University of Pennsylvania (Other)
Overall Status
Completed
CT.gov ID
NCT05186831
Collaborator
(none)
20
Enrollment
1
Location
2
Arms
2.9
Actual Duration (Months)
7
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The coronavirus disease 2019 (COVID-19) pandemic has uprooted conventional health care delivery for routine ambulatory care, requiring health systems to rapidly adopt telemedicine capabilities. The digital divide, has been well documented with lower rates of technology and broadband adoption among racial/ethnic minorities. Additionally, Black patients suffer a disproportionate burden of hypertension and cardiovascular disease. This study will implement a text-based home hypertension monitoring program among Black Medicaid patients with hypertension and cardiovascular disease (CVD) and compare its uptake to the currently available blood pressure monitoring program using the patient portal that is integrated into the electronic health record (EHR).

Condition or DiseaseIntervention/TreatmentPhase
  • Behavioral: Texting
  • Behavioral: Online patient portal
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Health Services Research
Official Title:
Patient-Portal vs Text-based Hypertension Monitoring Among Black Medicaid/Medicare Patients
Actual Study Start Date :
Oct 19, 2020
Actual Primary Completion Date :
Dec 29, 2020
Actual Study Completion Date :
Jan 14, 2021

Arms and Interventions

ArmIntervention/Treatment
Experimental: Text-based monitoring

Patients will be asked to take their BP two times daily and text their BP to the study phone number twice a day for 14 days.

Behavioral: Texting
Patients will be asked to text their BP. They will receive an automated response to their texts.

Active Comparator: Online patient portal

Patients will be asked to take their BP two times daily. They will be given instructions on how to upload BP readings to the online patient portal and will be asked to upload all BP readings. This represents enhanced standard of care.

Behavioral: Online patient portal
Patients will be asked to upload their BP to the online patient portal. They will receive information on how to sign up and use the patient portal. Patients can upload their BP readings daily or at the end of the study period.

Outcome Measures

Primary Outcome Measures

  1. Number of BP measurements reported [14 days]

    Number of BP results reported over the study period

  2. Proportion of patients submitting 1 or more BP measurement [14 days]

    Proportion of patients per study arm reporting at least one BP measurement

Secondary Outcome Measures

  1. Patient satisfaction [Within 2 weeks of end of study period]

    Patients will be asked to complete a survey about ease of use and likelihood of recommending the intervention

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Self-identified Black race

  • Medicaid or Medicare insurance

  • Hypertension

  • Cardiovascular disease or presence of at least 1 cardiovascular risk factor

  • Seen for in-person consultation at the Heart and Vascular clinic at the Hospital of the University of Pennsylvania

Exclusion Criteria:
  • Does not speak English

  • Already owns a BP cuff

  • Does not have internet access or a phone 15 with texting capabilities

Contacts and Locations

Locations

SiteCityStateCountryPostal Code
1University of PennsylvaniaPhiladelphiaPennsylvaniaUnited States19104

Sponsors and Collaborators

  • University of Pennsylvania

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jennifer Lewey, MD, MPH, Assistant Professor of Medicine, University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT05186831
Other Study ID Numbers:
  • University of Pennsylvania
First Posted:
Jan 11, 2022
Last Update Posted:
Jan 11, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jennifer Lewey, MD, MPH, Assistant Professor of Medicine, University of Pennsylvania
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 11, 2022